Biochemical Studies of CNS and PNS in Human and Experimental Diabetes

  • J. Palo
  • Edith Reske-Nielsen
  • P. Riekkinen
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 100)


Neuropathological evidence of encephalopathy and neuropathy has been found in all autopsied patients with long-term juvenile diabetes. Earlier biochemical studies of human post mortem specimens indicated extensive biochemical damage of the diabetic peripheral nerve but not of the brain. The activities of acid proteinase and phosphatase, β-glucosidase, β-glucosaminidase, glucose-6-phosphatase, succinyl dehydrogenase (SDH), and 2’,3’-cyclic nucleotide-3’-phosphohydrolase (CNP) were now measured from the brain homogenates of rats made diabetic with streptozotocin at the age of 1 month and killed after 1, 3, 6 and 15 months. The activities of acid proteinase and β-glucosidase decreased and that of SDH increased at the beginning of the experiment. A slight increase of acid phosphatase was noted at the end and a slight decrease of β-glucosaminidase at the beginning. The activities of SDH and CNP increased throughout the experiment both in the diabetic and control animals, probably due to maturation. In general, experimental streptozotocin diabetes induced few, transient and not very significant changes in enzymes known to be connected with myelination and demyelination in the CNS. The findings agree with those obtained previously for human diabetic specimens.


Sciatic Nerve Acid Phosphatase Peripheral Nervous System Diabetic Control Diabetic Animal 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Einstein, E.R., Dalal, K.B. and Csejtey, J., Increased protease activity and changes in basic proteins and lipids in multiple sclerosis plaques, J. neurol. Sci. 11 (1970) 109–121.PubMedCrossRefGoogle Scholar
  2. 2.
    Frey, H., Enzymes of central nervous system myelin with special reference to maturation. An experimental study on guinea-pigs, Doctoral thesis, University of Turku 1971.Google Scholar
  3. 3.
    Kurihara, T. and Tsukada, Y., The regional and subcellular distribution of 2’,3’-cyclic nucleotide-3’-phosphohydrolase in the central nervous system, J. Neurochem. 14 (1967) 1167–1174.PubMedCrossRefGoogle Scholar
  4. 4.
    Lehrer, G.M. and Bornstein, M.B., Carbohydrate matabolism of the developing brain in vivo and in vitro, in Abstracts of the International Neurochemical Conference, Oxford (1965) p. 68.Google Scholar
  5. 5.
    Palo, J., Reske-Nielsen, E. and Riekkinen, P., Enzyme and protein studies of demyelination in diabetes, J. neurol. Sci. 33 (1977) 171–178.PubMedCrossRefGoogle Scholar
  6. 6.
    Powell, H., Knox, D., Lee, S., Charters, A.C., Orloff, M., Garrett, R. and Lampert, P., Alloxan diabetic neuropathy: Electron microscopic studies, Neurology 27 (1977) 60–66.PubMedCrossRefGoogle Scholar
  7. 7.
    Reske-Nielsen, E., Pathology of the nervous system in diabetes, Meeting of the Scandinavian Diabetes Society, Aarhus 1973.Google Scholar
  8. 8.
    Riekkinen, P. and Clausen, J., Proteinase activity of myelin, Brain Res. 15 (1969) 413–430.PubMedCrossRefGoogle Scholar
  9. 9.
    Sharma, A.K. and Thomas, P.K., Peripheral nerve structure and function in experimental diabetes, J. neurol. Sei. 23 (1974) 1–15.CrossRefGoogle Scholar
  10. 10.
    Yonezawa, T., Bornstein, M.B., Peterson, E.R. and Murray, M.R., A histochemical study of oxidative enzymes in myelinating cultures of central and peripheral nervous tissue, J. Neuropath. exp. Neurol. 21 (1962) 479–487.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1978

Authors and Affiliations

  • J. Palo
    • 1
  • Edith Reske-Nielsen
    • 2
  • P. Riekkinen
    • 3
  1. 1.Department of NeurologyUniversity of HelsinkiFinland
  2. 2.Department of NeuropathologyAarhus University School of MedicineDenmark
  3. 3.Third Clinical Institute of Medicine/NeuroloyUniversity of TurkuFinland

Personalised recommendations